317 related articles for article (PubMed ID: 8690967)
1. Selective decrease of M. leprae-specific IgG1 and IgG3 antibodies in leprosy patients associated with ENL.
Kifayet A; Hussain R
Int J Lepr Other Mycobact Dis; 1996 Jun; 64(2):105-14. PubMed ID: 8690967
[TBL] [Abstract][Full Text] [Related]
2. IgG subclass recognition pattern in leprosy: recognition of M. leprae antigens by IgG1 and IgG3 antibodies is distinct across the disease spectrum.
Kifayet A; Hussain R
Int J Lepr Other Mycobact Dis; 1996 Mar; 64(1):69-78. PubMed ID: 8627117
[TBL] [Abstract][Full Text] [Related]
3. IgG subclass antibody to Mycobacterium leprae 18,000 MW antigen is restricted to IgG1 and IgG3 in leprosy.
Hussain R; Dockrell HM; Chiang TJ
Immunology; 1994 Nov; 83(3):495-500. PubMed ID: 7835976
[TBL] [Abstract][Full Text] [Related]
4. Determination of circulating IgG subclasses against lipoarabinomannan in the leprosy spectrum and reactions.
Beuria MK; Mohanty KK; Katoch K; Sengupta U
Int J Lepr Other Mycobact Dis; 1999 Dec; 67(4):422-8. PubMed ID: 10700917
[TBL] [Abstract][Full Text] [Related]
5. Humoral and cellular immune reactivity to recombinant M. leprae antigens in HLA-typed leprosy patients and healthy controls.
Klatser PR; Janson AM; Thole JE; Buhrer S; Bos C; Soebono H; de Vries RR
Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):178-89. PubMed ID: 9251589
[TBL] [Abstract][Full Text] [Related]
6. Erythema nodosum leprosum is associated with up-regulation of polyclonal IgG1 antibody synthesis.
Kifayet A; Shahid F; Lucas S; Hussain R
Clin Exp Immunol; 1996 Dec; 106(3):447-53. PubMed ID: 8973611
[TBL] [Abstract][Full Text] [Related]
7. Low serum HDL-cholesterol is associated with raised tumor necrosis factor-alpha during ENL reactions.
Memon RA; Kifayet A; Shahid F; Lateef A; Chiang J; Hussain R
Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):1-11. PubMed ID: 9207748
[TBL] [Abstract][Full Text] [Related]
8. Alterations in serum lipids in lepromatous leprosy patients with and without ENL reactions and their relationship to acute phase proteins.
Memon RA; Hussain R; Raynes JG; Lateff A; Chiang TJ
Int J Lepr Other Mycobact Dis; 1996 Jun; 64(2):115-22. PubMed ID: 8690968
[TBL] [Abstract][Full Text] [Related]
9. Sera of leprosy patients with type 2 reactions recognize selective sequences in Mycobacterium leprae recombinant LSR protein.
Singh S; Narayanan NP; Jenner PJ; Ramu G; Colston MJ; Prasad HK; Nath I
Infect Immun; 1994 Jan; 62(1):86-90. PubMed ID: 7505263
[TBL] [Abstract][Full Text] [Related]
10. Serum immune complexes in erythema nodosum leprosum reactions of leprosy.
Rao TD; Rao PR
Indian J Lepr; 1988 Apr; 60(2):189-95. PubMed ID: 3142953
[TBL] [Abstract][Full Text] [Related]
11. Differential immunoglobulin and complement levels in leprosy prior to development of reversal reaction and erythema nodosum leprosum.
Amorim FM; Nobre ML; Nascimento LS; Miranda AM; Monteiro GRG; Freire-Neto FP; Queiroz MDCP; Queiroz JW; Duthie MS; Costa MR; Reed SG; Johnson WD; Dupnik KM; Jeronimo SMB
PLoS Negl Trop Dis; 2019 Jan; 13(1):e0007089. PubMed ID: 30689631
[TBL] [Abstract][Full Text] [Related]
12. Class specific anti-Mycobacterium leprae antibody assay in lepromatous leprosy (BL-LL) patients during the first two to four years of DDS treatment.
Melsom R; Harboe M; Naafs B
Int J Lepr Other Mycobact Dis; 1982 Sep; 50(3):271-81. PubMed ID: 6754639
[TBL] [Abstract][Full Text] [Related]
13. Specificity of IgG subclass antibodies in different clinical manifestations of leprosy.
Dhandayuthapani S; Izumi S; Anandan D; Bhatia VN
Clin Exp Immunol; 1992 May; 88(2):253-7. PubMed ID: 1572088
[TBL] [Abstract][Full Text] [Related]
14. Levels of IgG subclasses in active and inactive cases in the disease spectrum of leprosy.
Beuria MK; Parkash O; Joshi B; Mohanty KK; Katoch K; Sengupta U
Int Arch Allergy Immunol; 1998 Jan; 115(1):61-6. PubMed ID: 9430497
[TBL] [Abstract][Full Text] [Related]
15. In situ and in vitro characterization of the cellular immune response in erythema nodosum leprosum.
Modlin RL; Mehra V; Jordan R; Bloom BR; Rea TH
J Immunol; 1986 Feb; 136(3):883-6. PubMed ID: 2416837
[TBL] [Abstract][Full Text] [Related]
16. Recognition of Mycobacterium leprae recombinant 18,000 MW epitopes by IgG subclasses in leprosy.
Hussain R; Menz B; Dockrell HM; Chiang TJ
Immunology; 1995 Feb; 84(2):290-7. PubMed ID: 7538491
[TBL] [Abstract][Full Text] [Related]
17. Delayed-type hypersensitivity reactions followed by erythema nodosum leprosum.
Rea TH; Sieling PA
Int J Lepr Other Mycobact Dis; 1998 Sep; 66(3):316-27. PubMed ID: 9934358
[TBL] [Abstract][Full Text] [Related]
18. Serum proteome of leprosy patients undergoing erythema nodosum leprosum reaction: regulation of expression of the isoforms of haptoglobin.
Gupta N; Shankernarayan NP; Dharmalingam K
J Proteome Res; 2007 Sep; 6(9):3669-79. PubMed ID: 17658739
[TBL] [Abstract][Full Text] [Related]
19. Suppressive effect of circulating immune complexes from leprosy patients on the lymphocyte proliferation induced by M. leprae antigens in healthy responders.
Tyagi P; Patil SA; Girdhar BK; Katoch K; Sengupta U
Int J Lepr Other Mycobact Dis; 1992 Dec; 60(4):562-9. PubMed ID: 1299711
[TBL] [Abstract][Full Text] [Related]
20. Clinical course of erythema nodosum leprosum: an 11-year cohort study in Hyderabad, India.
Pocaterra L; Jain S; Reddy R; Muzaffarullah S; Torres O; Suneetha S; Lockwood DN
Am J Trop Med Hyg; 2006 May; 74(5):868-79. PubMed ID: 16687695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
